Context-dependent perturbation of neural systems in transgenic mice expressing a cytosolic prion protein

We analyzed the relationship between pathogenic protein expression and perturbations to brain anatomy and physiology in a genetic model of prion disease. In this model, the mouse line 1D4, neuropathology is promoted by accumulation of a cytosolic form of the prion protein (cyPrP). CyPrP distribution was determined and compared with anatomical magnetic resonance imaging (MRI) data, a form of functional MRI based on manganese labeling, and immediate early gene mapping with an antibody to c-Fos. Significant discrepancies between 1D4 and control mice became apparent well in advance of overt behavioral pathology in the mutant mice. Alterations to brain structure and function in the mutants varied among brain regions, however, and differed strikingly even among regions with the highest levels of cyPrP expression. In the cerebellum, gross neurodegeneration was accompanied by increased Mn(2+)-enhanced MRI signal, raising the possibility that compensatory mechanisms act to preserve cerebellar function in the face of massive atrophy. In the hippocampus of 1D4 mice, no significant structural alterations were observed, but both Mn(2+)-enhanced MRI and c-Fos data indicated perturbations to neurophysiology. In the neocortex, there were no clear neural activity differences between 1D4 and control animals, but mutant mice showed significant reduction in cortical thickness. Our finding that distinct combinations of anatomical and functional abnormalities accompanied cyPrP overexpression in different parts of the brain indicates the importance of context in conditioning effects of protein pathogens, and exemplifies the notion that neurodegenerative phenotypes extend beyond cell death and the immediate consequences of atrophy for particular neural systems.

[1]  S. Prusiner.  Novel proteinaceous infectious particles cause scrapie. , 1982, Science.

[2]  A. Drzezga,et al.  Positron emission tomography with [18F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD) , 2002, Journal of Neurology.

[3]  D. Wirtshafter.  Cholinergic involvement in the cortical and hippocampal Fos expression induced in the rat by placement in a novel environment , 2005, Brain Research.

[4]  Ichio Aoki,et al.  Manganese‐enhanced magnetic resonance imaging (MEMRI): methodological and practical considerations , 2004, NMR in biomedicine.

[5]  A. Aguzzi,et al.  Prion protein (PrP) with amino‐proximal deletions restoring susceptibility of PrP knockout mice to scrapie. , 1996, The EMBO journal.

[6]  J. M. Ollinger,et al.  Positron Emission Tomography , 2018, Handbook of Small Animal Imaging.

[7]  M. Ghilardi,et al.  Increased cerebellar activation during sequence learning in DYT1 carriers: an equiperformance study. , 2007, Brain : a journal of neurology.

[8]  J. Rossier,et al.  Transmission of the BSE Agent to Mice in the Absence of Detectable Abnormal Prion Protein , 1997, Science.

[9]  Hong Yu,et al.  Role of hyperactive cerebellum and motor cortex in Parkinson's disease , 2007, NeuroImage.

[10]  Carlos Cepeda,et al.  Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect , 2004, Trends in Neurosciences.

[11]  Andrew D. Steele,et al.  The power of automated high-resolution behavior analysis revealed by its application to mouse models of Huntington's and prion diseases , 2007, Proceedings of the National Academy of Sciences.

[12]  R. Petersen,et al.  Fatal Familial Insomnia and Familial Creutzfeldt‐Jakob Disease: Clinical, Pathological and Molecular Features , 1995, Brain pathology.

[13]  F. Walker.  Huntington's disease , 2007, The Lancet.

[14]  A. Koretsky,et al.  Manganese ion enhances T1‐weighted MRI during brain activation: An approach to direct imaging of brain function , 1997, Magnetic resonance in medicine.

[15]  A. Johnston,et al.  Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie‐infected murine hippocampus , 2000, Neuropathology and applied neurobiology.

[16]  V. Perry,et al.  Neuropathologically distinct prion strains give rise to similar temporal profiles of behavioral deficits , 2005, Neurobiology of Disease.

[17]  Frank Angenstein,et al.  Manganese-enhanced MRI reveals structural and functional changes in the cortex of Bassoon mutant mice. , 2006, Cerebral cortex.

[18]  J. Taunton,et al.  Substrate-Specific Translocational Attenuation during ER Stress Defines a Pre-Emptive Quality Control Pathway , 2006, Cell.

[19]  M. Ghilardi,et al.  Enhancement of brain activation during trial-and-error sequence learning in early PD , 2003, Neurology.

[20]  J. Castilla,et al.  Perturbation of Endoplasmic Reticulum Homeostasis Facilitates Prion Replication* , 2007, Journal of Biological Chemistry.

[21]  Stephanie L. K. Bowers,et al.  Cytoplasmic prion protein induces forebrain neurotoxicity. , 2009, Biochimica et biophysica acta.

[22]  C. Blakemore,et al.  Environmental enrichment slows disease progression in R6/2 Huntington's disease mice , 2002, Annals of neurology.

[23]  P. Kahle.  alpha-Synucleinopathy models and human neuropathology: similarities and differences. , 2008, Acta neuropathologica.

[24]  X. Roucou,et al.  Cytosolic Prion Protein Is Not Toxic and Protects against Bax-mediated Cell Death in Human Primary Neurons* , 2003, Journal of Biological Chemistry.

[25]  D. Clayton,et al.  The Genomic Action Potential , 2000, Neurobiology of Learning and Memory.

[26]  Joseph A Frank,et al.  MRI of mouse models of neurological disorders , 2007, NMR in biomedicine.

[27]  E. Eidelberg,et al.  Recovery of locomotor function in cats after localized cerebellar lesions , 1983, Brain Research.

[28]  Afonso C. Silva,et al.  In vivo neuronal tract tracing using manganese‐enhanced magnetic resonance imaging , 1998, Magnetic resonance in medicine.

[29]  Harry T Orr,et al.  Trinucleotide repeat disorders. , 2007, Annual review of neuroscience.

[30]  P. Kahle.  α-Synucleinopathy models and human neuropathology: similarities and differences , 2007, Acta Neuropathologica.

[31]  J. Castilla,et al.  Caspase‐12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein , 2003, The EMBO journal.

[32]  Shu G. Chen,et al.  Sporadic and familial CJD: classification and characterisation. , 2003, British medical bulletin.

[33]  S. Lindquist,et al.  Neurotoxicity and Neurodegeneration When PrP Accumulates in the Cytosol , 2002, Science.

[34]  R. Hegde,et al.  Reduced translocation of nascent prion protein during ER stress contributes to neurodegeneration. , 2008, Developmental cell.

[35]  Ichio Aoki,et al.  In vivo detection of neuroarchitecture in the rodent brain using manganese-enhanced MRI , 2004, NeuroImage.

[36]  S. Betmouni,et al.  An integrated, temporal study of the behavioural, electrophysiological and neuropathological consequences of murine prion disease , 2006, Neurobiology of Disease.

[37]  B. Ghetti,et al.  Neurological Illness in Transgenic Mice Expressing a Prion Protein with an Insertional Mutation , 1998, Neuron.

[38]  L. Arterburn,et al.  The Interaction between Cytoplasmic Prion Protein and the Hydrophobic Lipid Core of Membrane Correlates with Neurotoxicity* , 2006, Journal of Biological Chemistry.

[39]  L. Mucke,et al.  A network dysfunction perspective on neurodegenerative diseases , 2006, Nature.

[40]  S. Prusiner,et al.  Scrapie infection of transgenic mice leads to network and intrinsic dysfunction of cortical and hippocampal neurones , 1994, Neurobiology of Disease.

[41]  Hyoung-Gon Lee,et al.  Neuropathology and treatment of Alzheimer disease: did we lose the forest for the trees? , 2007, Expert review of neurotherapeutics.

[42]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[43]  H. Engler,et al.  Multitracer study with positron emission tomography in Creutzfeldt-Jakob disease , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[44]  S. Prusiner,et al.  Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein , 1992, Nature.

[45]  Michael Brady,et al.  Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images , 2002, NeuroImage.

[46]  Scott T. Grafton,et al.  Automated image registration: I. General methods and intrasubject, intramodality validation. , 1998, Journal of computer assisted tomography.

[47]  G. Muehllehner,et al.  Positron emission tomography , 2006, Physics in medicine and biology.

[48]  A. Aguzzi,et al.  Mammalian Prion Biology One Century of Evolving Concepts , 2004, Cell.

[49]  R. Chiesa,et al.  Conditions of Endoplasmic Reticulum Stress Favor the Accumulation of Cytosolic Prion Protein* , 2006, Journal of Biological Chemistry.

[50]  D L Price,et al.  A vector for expressing foreign genes in the brains and hearts of transgenic mice. , 1996, Genetic analysis : biomolecular engineering.

[51]  S. Prusiner,et al.  Spontaneous neurodegeneration in transgenic mice with mutant prion protein , 1990, Science.

[52]  R. S. Stewart,et al.  Cytosolic Prion Protein (PrP) Is Not Toxic in N2a Cells and Primary Neurons Expressing Pathogenic PrP Mutations* , 2005, Journal of Biological Chemistry.

[53]  Belma Dogdas,et al.  Segmentation of skull and scalp in 3‐D human MRI using mathematical morphology , 2005, Human brain mapping.

[54]  R. Hegde,et al.  Protection from cytosolic prion protein toxicity by modulation of protein translocation , 2004, The EMBO journal.

[55]  V. Perry,et al.  Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease , 2003, The European journal of neuroscience.